MCM
Moore Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-250,000
| Closed | -$20.6M | – | 408 |
|
|
2024
Q2 | $20.6M | Sell |
250,000
-10,000
| -4% | -$823K | 0.36% | 70 |
|
|
2024
Q1 | $22.7M | Buy |
260,000
+50,000
| +24% | +$4.37M | 0.36% | 52 |
|
|
2023
Q4 | $20.2M | Buy |
210,000
+14,800
| +8% | +$1.43M | 0.35% | 44 |
|
|
2023
Q3 | $17.3M | Buy |
195,200
+35,200
| +22% | +$3.11M | 0.32% | 45 |
|
|
2023
Q2 | $13.9M | Buy |
160,000
+130,000
| +433% | +$11.3M | 0.24% | 66 |
|
|
2023
Q1 | $2.92M | Sell |
30,000
-100,000
| -77% | -$9.72M | 0.06% | 185 |
|
|
2022
Q4 | $13.5M | Buy |
130,000
+76,012
| +141% | +$7.87M | 0.32% | 43 |
|
|
2022
Q3 | $4.58M | Sell |
53,988
-20,576
| -28% | -$1.74M | 0.11% | 195 |
|
|
2022
Q2 | $6.18M | Buy |
74,564
+17,207
| +30% | +$1.43M | 0.16% | 124 |
|
|
2022
Q1 | $4.42M | Sell |
57,357
-114,714
| -67% | -$8.84M | 0.11% | 211 |
|
|
2021
Q4 | $15.2M | Buy |
+172,071
| New | +$15.2M | 0.3% | 54 |
|
|
2016
Q1 | – | Sell |
-122,000
| Closed | -$12.8M | – | 230 |
|
|
2015
Q4 | $12.8M | Buy |
+122,000
| New | +$12.8M | 0.4% | 69 |
|
|
2015
Q2 | – | Sell |
-27,500
| Closed | -$3.43M | – | 368 |
|
|
2015
Q1 | $3.43M | Sell |
27,500
-28,600
| -51% | -$3.56M | 0.08% | 170 |
|
|
2014
Q4 | $5.07M | Buy |
+56,100
| New | +$5.07M | 0.16% | 107 |
|
|
2013
Q4 | – | Sell |
-62,500
| Closed | -$4.51M | – | 311 |
|
|
2013
Q3 | $4.51M | Buy |
+62,500
| New | +$4.51M | 0.1% | 120 |
|